Pharmaceuticals in Italy

The Pharmaceuticals in Italy industry profile is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

- Contains an executive summary and data on value, volume and/or segmentation

- Provides textual analysis of Pharmaceuticals in Italy’s recent performance and future prospects

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes a five-year forecast of Pharmaceuticals in Italy

- The leading companies are profiled with supporting key financial metrics

- Supported by the key macroeconomic and demographic data affecting the market

Highlights

- Detailed information is included on market size, measured by value and/or volume

- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

- Market shares are covered by manufacturer or brand

Why you should buy this report

- Spot future trends and developments

- Inform your business decisions

- Add weight to presentations and marketing materials

- Save time carrying out entry-level research

Market Definition

The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant annual average exchange rates. For the purpose of this report Europe is deemed to comprise of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom. SHOW LESS READ MORE >

EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
GlaxoSmithKline Plc
Menarini Group
Pfizer Inc.
MARKET FORECASTS
Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting

LIST OF TABLES
Table 1: Italy pharmaceuticals market value: $ billion, 2006–10(e)
Table 2: Italy pharmaceuticals market segmentation I:% share, by value, 2010(e)
Table 3: Italy pharmaceuticals market segmentation II: % share, by value, 2010(e)
Table 4: Italy pharmaceuticals market share: % share, by value, 2010(e)
Table 5: GlaxoSmithKline Plc: key facts
Table 6: GlaxoSmithKline Plc: key financials ($)
Table 7: GlaxoSmithKline Plc: key financials (£)
Table 8: GlaxoSmithKline Plc: key financial ratios
Table 9: Menarini Group: key facts
Table 10: Pfizer Inc.: key facts
Table 11: Pfizer Inc.: key financials ($)
Table 12: Pfizer Inc.: key financial ratios
Table 13: Italy pharmaceuticals market value forecast: $ billion, 2010–15
Table 14: Italy size of population (million), 2006–10
Table 15: Italy GDP (constant 2000 prices, $ billion), 2006–10
Table 16: Italy GDP (current prices, $ billion), 2006–10
Table 17: Italy inflation, 2006–10
Table 18: Italy consumer price index (absolute), 2006–10
Table 19: Italy exchange rate, 2006–10

LIST OF FIGURES
Figure 1: Italy pharmaceuticals market value: $ billion, 2006–10(e)
Figure 2: Italy pharmaceuticals market segmentation I:% share, by value, 2010(e)
Figure 3: Italy pharmaceuticals market segmentation II: % share, by value, 2010(e)
Figure 4: Italy pharmaceuticals market share: % share, by value, 2010(e)
Figure 5: Forces driving competition in the pharmaceuticals market in Italy, 2010
Figure 6: Drivers of buyer power in the pharmaceuticals market in Italy, 2010
Figure 7: Drivers of supplier power in the pharmaceuticals market in Italy, 2010
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Italy, 2010
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Italy, 2010
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Italy, 2010
Figure 11: GlaxoSmithKline Plc: revenues & profitability
Figure 12: GlaxoSmithKline Plc: assets & liabilities
Figure 13: Pfizer Inc.: revenues & profitability
Figure 14: Pfizer Inc.: assets & liabilities
Figure 15: Italy pharmaceuticals market value forecast: $ billion, 2010–15

- GlaxoSmithKline Plc
- Menarini Group
- Pfizer Inc
- Sanofi-Aventis